Background To investigate the time to initial sputum culture conversion (SCC) and its predictors among multidrug-resistant tuberculosis (MDR-TB) patients in Hangzhou, China.Methods A retrospective cohort study was conducted among patients initiating treatment for MDR-TB from 2011-2015 in Hangzhou, China. Time to initial SCC was analyzed using the Kaplan-Meier method, and Cox proportional hazards regression was used to identify predictors of SCC.Results Among 384 patients enrolled with MDR-TB, 359 (93.5%) successfully achieved initial SCC after a median of 85 days (inter-quartile range, 40-112 days). A higher rate of SCC was observed in participants with successful treatment outcomes than those with poor treatment outcomes (P<0.01). Multivariate analysis showed that age 25-64 years (adjusted odds ratio [AOR], 0.7; 95% confidence interval [CI], 0.5-0.9; P<0.01), age ≥65 years (AOR, 0.5; 95%CI, 0.3-0.8; P<0.01) and household registration in Hangzhou (AOR, 1.3; 95%CI, 1.0-1.5; P<0.05) were found to be associated with SCC.Conclusions Although high SCC and treatment success rates were observed among MDR-TB patients in Hangzhou, the prolonged duration to initial SCC underscores the importance of emphasizing measures for infection control. A new policy of shifting outpatient treatment to inpatient treatment in China may reduce the risk of transmission from patients in the time window prior to SCC.
Background: So far, there are few studies that have investigated the risk of incident multidrug-resistant tuberculosis (MDR-TB) among individuals with previous tuberculosis history (PTBH), let alone developed a nomogram so as to comprehensively estimate an individualized risk of incident MDR-TB in this population. The present study was to construct a comprehensive nomogram for providing simple and precise personalized prediction of incident MDR-TB risk among individuals with PTBH.Methods: A matched case−control study (1: 2 ratios) was performed between 2005 and 2018 in Hangzhou City, China. A multivariable Cox proportional hazard regression was used to evaluate independent predictors of incident MDR-TB in individuals with PTBH. A comprehensive nomogram was developed based on the multivariable Cox model.Results: Overall, 1, 836 participants were included in this study. We developed a simple-to-use nomogram for predicting the individualized risk of incident MDR-TB by using the parameters of age < 60 years, a history of direct contact, passive mode of TB case finding, human immunodeficiency virus infection, re-treated TB history, unsuccessful treatment, 3HRZES/6HRE, duration of pulmonary cavities, and duration of positive sputum culture in individuals with PTBH. The concordance index of this nomogram was 0.833 [95% confidence interval (CI): 0.807-0.859] and 0.871 (95% CI 0.773-0.969) for the training and validation sets, respectively, which indicated adequate discriminatory power. The calibration curves for the risk of incident MDR-TB showed an optimal agreement between nomogram prediction and actual observation in the training and validation sets, respectively. The high sensitivity and specificity of nomogram was indicated by using a receiver operating characteristic curve analysis.Conclusions: We developed and validated a novel nomogram for predicting and preventing the risk of incident MDR-TB in individuals with PTBH. Through this clinic tool, TB control executives could more precisely monitor, estimate and intervene the risk of incident MDR-TB among individual PTB patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.